UPDATE: Proton Pump Inhibitor Litigation (“PPI”) – Prilosec, Nexium, Prevacid, Dexilant

Posted on April 8, 2024
In August of 2017, this Multi-District Litigation (“MDL”) was assigned to the Honorable Claire Cecchi in the District Court of New Jersey.  As of August of 2023, there were approximately 12,500 cases pending in the MDL, making the PPI (proton-pump inhibitor) MDL the 5th largest in the country. The crux of these claims involve the failure of the defendant-manufacturer pharmaceutical...
Read Full Post

Lawsuits Against Foreign Manufacturers: Difficulties Obtaining Jurisdiction

Posted on April 5, 2024
By Larry Coben, Anapol Weiss Shareholder Published: The Legal Intelligencer Every day, consumers, workers, and sports enthusiasts use products made in other countries and then imported to the United States. Imports of consumer goods to the United States reached an all-time high in 2022. Americans’ reliance on and use of products designed, manufactured, and then imported to the U.S. from...
Read Full Post

Discrimination In Maternal Healthcare Is Real

Posted on March 27, 2024
By Kila Baldwin It was reported this morning that former Kansas City Chiefs cheerleader Krystal Anderson passed away unexpectedly after giving birth to a stillborn infant. Anderson’s cause of death was stated to be sepsis, and little is being reported at this point about the cause of the infection, the specific prenatal care she was receiving, or the cause of...
Read Full Post

Forum Selection—Forum Non ‘Convenience’: No Need for ‘Corrective Action’

Posted on March 27, 2024
By Larry Coben, Anapol Weiss Shareholder Published in: The Legal Intelligencer Summary: Despite the underlying motivations, or perhaps because of them, the legal grounds for a request to change venue based upon “forum non conveniens” has evolved into a war of words in which our trial courts are asked to decide whether the plaintiff’s selected forum is “vexatious” or “oppressive,”...
Read Full Post

The Vital Role of Bilingual Attorneys in Personal Injury Cases

Posted on March 13, 2024
In today’s multicultural society, the ability to communicate effectively in multiple languages is more than a skill—it’s a necessity, especially in the legal realm. Anapol Weiss proudly highlights its commitment to serving diverse communities through its team of bilingual attorneys. This blog post delves into why bilingual attorneys are critical in personal injury cases. Effective Communication: Understanding and navigating personal...
Read Full Post

How to Transfer Your Loved One to a New Nursing Home

Posted on November 1, 2023
Introduction: Transferring a loved one to a new nursing home can be a challenging decision, but it's sometimes necessary to ensure their well-being and quality of care. This step-by-step guide will help you navigate the process effectively, ensuring your loved one's comfort and safety. 1. Assess the Need for a Transfer: Why do you want to transfer your loved one?...
Read Full Post

Navigating the VICP system

Posted on August 21, 2023
As summer begins to come to an end, we are steadily approaching influenza (flu) season. The flu is characterized as an acute respiratory infection caused mainly by two of the four types of influenza viruses, Influenza A viruses and Influenza B viruses, that circulates globally. To prevent a seasonal flu epidemic, the CDC recommends that individuals 6 months and older...
Read Full Post

US Supreme Court agrees with the legal arguments voiced by our shareholder Larry E. Coben

Posted on June 28, 2023
On June 27, 2023, the United States Supreme Court agreed with the legal arguments voiced by our shareholder Larry E. Coben, who authored an Amicus Brief for the Center for Auto Safety and the Attorneys Information Exchange Group in Mallory v. Norfolk Southern Railway Co., 600 U. S. ___ (2023). The result of this ruling is to open the doors...
Read Full Post

COVID-19 Vaccine Injuries and the National Vaccine Injury Compensation Program:

Posted on April 25, 2023
While the National Vaccine Injury Compensation Program (VICP) does not yet cover COVID-19 vaccines, the National Academy of Sciences, Engineering, and Medicine (NASEM) is currently reviewing the issue of COVID-19 vaccine adverse events and their potential inclusion in the VICP. These include: Guillain-Barrè Syndrome (GBS) Chronic inflammatory demyelinating polyneuropathy (CIDP) Transverse myelitis (TM) Bell’s palsy Hearing loss Chronic headaches Infertility...
Read Full Post

CDC and FDA Issues New Warnings and Additional Recall Notices: Drug-resistant bacteria connected to eye drops leads to 3 deaths, 8 reported cases of vision loss, and 4 reports of surgical removal of eyeballs

Posted on March 14, 2023
After the recall of EzriCare & Delsma Pharma: Artificial Tears Lubricant Eye Drops in February 2023, the U.S. Food and Drug Administration (FDA) has now issued voluntary recall of two more eye drops. Apotex and Pharmedica, the drugs' companies, said they recalled their products, Apotex: Brimonidine Tartrate Ophthalmic Solution, 0.15%, and Purely Soothing: 15% MSM Drops, respectively, due to sterility...
Read Full Post

2023 Fabuloso Multi-Purpose Cleaners Recall & Class Action Lawsuit

Posted on February 17, 2023
Colgate-Palmolive has recently announced a recall of its popular Fabuloso Multi-Purpose Cleaners due to concerns that the products may expose consumers to harmful bacteria. This Feb. 8, 2023 recall was in cooperation with the Consumer Product Safety Commission (CPSC). Consumers who have purchased these products are recommended to stop using them immediately. Why were the Fabuloso products recalled? The recall...
Read Full Post

The United States Court of Federal Claims (Court of Federal Claims)

Posted on February 6, 2023
Did you know that there is a court in Washington D.C. that devotes part of its resources to litigating cases filed on behalf of individuals injured by certain vaccines? The United States Court of Federal Claims (Court of Federal Claims) does just that. In October 1988, the National Vaccine Injury Compensation Program (VICP) was created as part of the Court...
Read Full Post